ACP

Arrowgrass Capital Partners Portfolio holdings

AUM $266K
This Quarter Return
+1.26%
1 Year Return
3 Year Return
5 Year Return
10 Year Return
AUM
$130M
AUM Growth
+$130M
Cap. Flow
+$13.7M
Cap. Flow %
10.5%
Top 10 Hldgs %
97.75%
Holding
23
New
6
Increased
3
Reduced
1
Closed
6

Sector Composition

1 Communication Services 79.58%
2 Healthcare 7.05%
3 Industrials 3.68%
4 Materials 1.91%
5 Energy 1.66%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
META icon
1
Meta Platforms (Facebook)
META
$1.86T
$57.5M 30.63% 640,082 +422,049 +194% +$37.9M
GOOG icon
2
Alphabet (Google) Class C
GOOG
$2.58T
$30.3M 16.12% 47,428 +27,500 +138% +$17.6M
TTWO icon
3
Take-Two Interactive
TTWO
$43B
$11.3M 6.04% 395,000 -259,458 -40% -$7.45M
ESRX
4
DELISTED
Express Scripts Holding Company
ESRX
$8.1M 4.31% +100,000 New +$8.1M
BID
5
DELISTED
Sotheby's
BID
$4.8M 2.55% +150,000 New +$4.8M
GM.WS.B
6
DELISTED
General Motors Company
GM.WS.B
$4.67M 2.49% 353,583
LILAK icon
7
Liberty Latin America Class C
LILAK
$1.65B
$4.45M 2.37% +130,000 New +$4.45M
AU icon
8
AngloGold Ashanti
AU
$28.6B
$2.49M 1.32% 303,400 +75,400 +33% +$618K
KMI icon
9
Kinder Morgan
KMI
$60B
$2.16M 1.15% +78,000 New +$2.16M
GM icon
10
General Motors
GM
$55.8B
$1.44M 0.77% 47,900
BXLT
11
DELISTED
BAXALTA INC COM STK (DE)
BXLT
$1.1M 0.59% +35,000 New +$1.1M
ABBV icon
12
AbbVie
ABBV
$372B
$1.09M 0.58% +20,000 New +$1.09M
OIBR
13
DELISTED
OI S A SPONSORED ADR REPSTG PFD NEW (BRA)
OIBR
$732K 0.39% 1,082,922
GM.WS.A
14
DELISTED
GENERAL MOTORS COMPANY WARRANT (EXPIRES 07/10/2016)
GM.WS.A
$13K 0.01% 660
AA icon
15
Alcoa
AA
$8.33B
-45,000 Closed -$502K
C icon
16
Citigroup
C
$178B
0
DFS
17
DELISTED
Discover Financial Services
DFS
-300,000 Closed -$17.3M
DIS icon
18
Walt Disney
DIS
$213B
-200,494 Closed -$22.9M
NVDA icon
19
NVIDIA
NVDA
$4.24T
-390,000 Closed -$7.84M
PBR icon
20
Petrobras
PBR
$79.9B
0
PPLT icon
21
abrdn Physical Platinum Shares ETF
PPLT
$1.58B
-15,000 Closed -$1.56M
UBS icon
22
UBS Group
UBS
$128B
-333,333 Closed -$6.61M
VRTX icon
23
Vertex Pharmaceuticals
VRTX
$100B
0